These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27756332)

  • 1. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis.
    Yang R; Yang S; Li R; Liu P; Qiao J; Zhang Y
    Reprod Biol Endocrinol; 2016 Oct; 14(1):67. PubMed ID: 27756332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome.
    Wen X; Wang L; Bai E
    Front Endocrinol (Lausanne); 2024; 15():1370578. PubMed ID: 39109080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
    Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
    Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
    Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Amiri M; Tehrani FR; Bidhendi-Yarandi R; Behboudi-Gandevani S; Azizi F; Carmina E
    Horm Metab Res; 2019 Jan; 51(1):22-34. PubMed ID: 30650457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
    He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
    Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity.
    Couto Alves A; Valcarcel B; Mäkinen VP; Morin-Papunen L; Sebert S; Kangas AJ; Soininen P; Das S; De Iorio M; Coin L; Ala-Korpela M; Järvelin MR; Franks S
    Int J Obes (Lond); 2017 Sep; 41(9):1331-1340. PubMed ID: 28546543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome.
    Ezeh U; Chen YI; Pall M; Buyalos RP; Chan JL; Pisarska MD; Azziz R
    Fertil Steril; 2024 Jun; 121(6):1040-1052. PubMed ID: 38307453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements.
    Yang Y; Ding M; Di N; Azziz R; Yang D; Zhao X
    J Clin Lab Anal; 2019 Mar; 33(3):e22699. PubMed ID: 30350882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
    Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
    Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
    Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
    J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.
    Albu A; Radian S; Fica S; Barbu CG
    Endocrine; 2015 Mar; 48(2):696-704. PubMed ID: 25022659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
    Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
    J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
    Lim SS; Kakoly NS; Tan JWJ; Fitzgerald G; Bahri Khomami M; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
    Obes Rev; 2019 Feb; 20(2):339-352. PubMed ID: 30339316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.